🇺🇸 Ginkgolides Meglumine Injection in United States

Ginkgolides Meglumine Injection (Ginkgolides Meglumine Injection) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Ginkgolides Meglumine Injection in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Ginkgolides Meglumine Injection approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Ginkgolides Meglumine Injection in United States?

Jiangsu Kanion Pharmaceutical Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.